x
0
SCOTTRADE ACCOUNT IT'S TIME. It's time for an easier way to invest. Open a Scottrade Account
Apply Now

Amgen Inc (AMGN)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Amgen's earnings

Delivery

Website notifications

Mobile App notifications

Add to/Remove from a Portfolio My Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
163.14 +2.73    +1.70%
24/04 - Closed. Currency in USD ( Disclaimer )
After Hours
163.35
+0.21
+0.13%
20:55:29 GMT - Real-time Data
Type: Equity
Market: United States
ISIN: US0311621009 
CUSIP: 031162100
  • Volume: 3,491,407
  • Bid/Ask: 163.00 / 163.63
  • Day's Range: 161.90 - 163.60
Start Trading
Amgen 163.14 +2.73 +1.70%

AMGN Overview

 
Information about the Amgen Inc Stock. You can find more details by going to one of the sections under this page such as historical data, charts, technical analysis and others.
Loading
Last Update:
  • 1 Day
  • 1 Week
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 5 years
  • Max
Prev. Close160.41
Day's Range161.9 - 163.6
Revenue22.99B
Open162.5
52 wk Range133.64 - 184.21
EPS10.26
Volume3,491,407
Market Cap118.04B
Dividend (Yield)4 (2.87%)
Average Vol. (3m)3,494,685
P/E Ratio15.63
Beta1.29
1-Year Change - 1.7%
Shares Outstanding735,890,171
Next Earnings DateApr 26, 2017

Technical Summary

Type 5 mins 15 mins Hourly Daily Monthly
Moving Averages Strong Buy Buy Buy Buy Buy
Technical Indicators Strong Buy Strong Buy Strong Buy Sell BUY
Summary Strong Buy Strong Buy Strong Buy Neutral Buy

Candlestick Patterns

 

Filter Table By:

Candle Sticks Characteristics:

Time Frame
Type
Pattern Indication
Reliability
Pattern Timeframe Reliability Candles Ago Candle Time
Emerging Patterns
Shooting Star 1H Current
Completed Patterns
Engulfing Bearish 1D 1 Apr 21, 2017
Doji Star Bearish 1H 1 Apr 24, 2017 02:00PM
Three Outside Down 1W 5 Mar 19, 2017

Amgen Inc News & Analysis

Amgen Inc Quotes

Exchange Last Bid Ask Volume Change % Currency Time
  NASDAQ 163.14 163.00 163.63 3,491,407 +1.70% USD 24/04  
  Mexico 3,069.11 0.00 0.00 0 0.00% MXN 20/04  
  Switzerland 162.60 140.00 170.00 0 0.00% CHF 19/04  
  Berlin 148.67 150.16 150.49 0 -1.59% EUR 24/04  
  Munich 150.23 0.00 0.00 111 -0.44% EUR 24/04  
  Xetra 149.65 149.55 149.70 3,132 -0.76% EUR 24/04  
  Stuttgart 150.21 0.00 0.00 50 -0.48% EUR 24/04  
  Frankfurt 149.50 150.20 150.52 2,482 -1.53% EUR 24/04  
  TradeGate 150.26 149.89 150.34 2,460 -0.16% EUR 24/04  
  Hong Kong 444.00 0.00 0.00 0 0.00% HKD 29/07  

Trending Stocks

Create Alert
Add to Portfolio
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery

Website notifications

Mobile App notifications

  Name Last High Low Chg. Chg. % Vol. Time
  Apple 143.64 143.95 143.18 +1.37 +0.96% 17.12M 24/04  
  Barrick Gold 19.04 19.26 18.82 -0.19 -0.99% 14.29M 24/04  
  Tesla 308.03 310.55 306.02 +2.43 +0.80% 5.08M 24/04  
  T-Mobile US Inc 65.93 65.97 64.97 +1.23 +1.90% 5.55M 24/04  
  Amazon.com 907.41 909.99 903.82 +8.88 +0.99% 3.12M 24/04  
  Bank of America 23.63 23.85 23.24 +0.92 +4.05% 138.50M 24/04  
  Facebook 145.47 145.67 144.34 +1.79 +1.25% 14.40M 24/04  
  Netflix 143.83 144.50 143.40 +0.96 +0.67% 4.79M 24/04  
  AMD 13.130 13.230 13.045 +0.130 +1.00% 36.11M 24/04  
  Alphabet Inc C 862.76 863.45 849.86 +19.57 +2.32% 1.37M 24/04  

Amgen Inc Company Profile

IndustryBiotechnology & Drugs
SectorHealthcare
Employees

19200

Equity Type

ORD

Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. Its marketed products portfolio includes Neulasta (pegfilgrastim); erythropoiesis-stimulating agents (ESAs), such as Aranesp (darbepoetin alfa) and EPOGEN (epoetin alfa); Sensipar/Mimpara (cinacalcet); XGEVA (denosumab); Prolia (denosumab); NEUPOGEN (filgrastim), and other marketed products, such as KYPROLIS (carfilzomib), Vectibix (panitumumab), Nplate (romiplostim), Repatha (evolocumab), BLINCYTO (blinatumomab), IMLYGIC (talimogene laherparepvec) and Corlanor (ivabradine). It focuses on human therapeutics for the treatment of serious illness in the areas of oncology/hematology, cardiovascular disease and neuroscience. Its product candidates in Phase III include Erenumab for episodic migraine, Aranesp for myelodysplastic syndromes, BLINCYTO for acute lymphoblastic leukemia and IMLYGIC for metastatic melanoma.

Read More

Start Trading With Top Industry Brokers

Brokers Regulation Minimum Deposit
Financial Industry Regulatory Authority (United States), Securities Investor Protection Corporation (United States) $1000 Start Trading
U.S. Commodity Futures Trading Commission (United States) $250 Start Trading

My Sentiments

Add your sentiment:
or
 
Members' Sentiments:
Bullish
0%
Bearish
100%

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

 
Are you sure you want to delete this chart?
 
 
Replace the attached chart with a new chart ?
Post 1000
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.

Latest AMGN Comments

anshum gupta
anshum gupta May 16, 2016 7:25AM GMT
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Possibility of a correction from the current levels, but it becomes a good buy in between 144.5-147.5 for the targets of 157.5/159.35/173.3/180. If kept from a longer term perspective, then ultimate target of 210 and above is possible. Keep a stop loss of below 137.5 on a monthly closing basis. Happy investing!!!!
Christian Heine
Christian Heine Oct 28, 2016 2:03PM GMT
Saved. See Saved Items.
This comment has already been saved in your Saved Items
The correction should have occured in after trades...speculative attack..
 
Are you sure you want to delete this chart?
 
 
Replace the attached chart with a new chart ?
Post 1000
Please wait a minute before you try to comment again.
 
 
 
Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Add Chart to Comment
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.